Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus.

Bibliographic Information

Title
Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus.
Author
Yamamoto M (3番目, 他6名)
Published
2010
Resource Type
journal article

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010000782059424642
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top